Vaccinations

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

Clinical trial finds COVID antibody drug can prevent infection

Uninfected people lived with one infected individual as part of the study - the COVID antibody drug gave them 72% protection against catching the virus themselves.

Center for Disease Control says surfaces “low-risk” for COVID transmission

New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.

REACT study: Primary school children have highest COVID infection level

New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.

Healthy under-30s should take alternative vaccine to AstraZeneca

The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.

Breast milk may protect babies against COVID-19

A new study by Washington University School of Medicine suggests that breastfeeding mothers may pass protective COVID-19 antibodies to their babies through breast milk for at least 80 days following vaccination.

Moderna COVID vaccine rollout begins in UK

The Moderna COVID vaccine will initially be given to patients in Wales - which brings the UK up to three approved vaccines.

VMIC: A base for worldwide collaboration in the development of vaccines

We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.

Johnson & Johnson factory accident damages 15 million vaccine doses

A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.

Scientists find Pfizer vaccine is 100% effective in young adolescents

The company aim to start vaccinating children by September 2021, as clinical trials reveal that Pfizer is 100% effective in those aged 12 to 15.

Moderna and Pfizer vaccines 90% effective in US real-world data

Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.

Biosimilars: Improve access to treatment & reduce cost

Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.

Data shows 49% of Black British adults want COVID vaccine

ONS data from January shows that only 49% of Black British adults would take the COVID vaccine - the UK Government acknowledges that others are wary about the intention of "some institutions and authorities".

Data finds 36% of people refuse COVID vaccine due to side effect fears

According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.

Zebra Technologies: Dedicated to improving global health

We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.

AstraZeneca vaccines made for UK could be kept for EU use only

EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.

Poll finds 61% of people in France think AstraZeneca vaccine is unsafe

According to a new YouGov poll, 61% of people in France now believe that the AstraZeneca vaccine is unsafe, with Germany following closely at 55% - creating fears about the potential impact of vaccine hesitancy on the rollout.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders